SOADOR
ALNY icon

State of Alaska Department of Revenue’s Alnylam Pharmaceuticals ALNY Stock Holding History

State of Alaska Department of Revenue’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,030
Closed -$558K – 1589
2024
Q3 		$558K Sell
2,030
-2,245
-53% -$585K 0.01% 1373
2024
Q2 		$1.04M Buy
+4,275
New +$675K 0.01% 981
2021
Q2 		– Sell
-34,017
Closed -$4.8M – 1644
2021
Q1 		$4.8M Sell
34,017
-4,148
-11% -$624K 0.05% 383
2020
Q4 		$4.96M Sell
38,165
-4,097
-10% -$547K 0.06% 360
2020
Q3 		$6.15M Buy
42,262
+14,054
+50% +$2M 0.08% 294
2020
Q2 		$4.18M Buy
+28,208
New +$3.8M 0.05% 410
2019
Q3 		– Sell
-11,061
Closed -$802K – 1638
2019
Q2 		$802K Buy
11,061
+152
+1% +$11.7K 0.01% 852
2019
Q1 		$1.02M Buy
10,909
+86
+0.8% +$7.19K 0.02% 719
2018
Q4 		$789K Buy
10,823
+71
+0.7% +$5.46K 0.02% 748
2018
Q3 		$940K Buy
10,752
+292
+3% +$29.4K 0.02% 754
2018
Q2 		$1.03M Buy
10,460
+2,590
+33% +$257K 0.02% 695
2018
Q1 		$936K Buy
7,870
+1,570
+25% +$202K 0.02% 699
2017
Q4 		$800K Buy
+6,300
New +$792K 0.02% 671

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State of Alaska Department of Revenue's ALNY Position: Q4 2024 in Review

State of Alaska Department of Revenue sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2024, closing a stake of 2,030 shares — an estimated $558K sold.

State of Alaska Department of Revenue first reported a position in ALNY in Q4 2017 and held it in 13 quarters. The position peaked at $6.15M in Q3 2020. 594 funds tracked by Wall St. Rank hold ALNY as of Q4 2024.

  • State of Alaska Department of Revenue reported no remaining Alnylam Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 2,030 Alnylam Pharmaceuticals shares in Q4 2024, an estimated $558K.
  • State of Alaska Department of Revenue first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 13 quarters.
  • State of Alaska Department of Revenue's Alnylam Pharmaceuticals position peaked at $6.15M in Q3 2020.
  • 594 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2024.

Based on State of Alaska Department of Revenue's 13F filing for Q4 2024, filed 27 Jan 2025.